Novo Integrated Sciences Pre-Tax Profit Margin 2012-2024 | NVOS
Novo Integrated Sciences pre-tax profit margin from 2012 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Novo Integrated Sciences Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-02-29 |
$0.01B |
$-0.01B |
-92.31% |
| 2023-11-30 |
$0.01B |
$-0.01B |
-107.69% |
| 2023-08-31 |
$0.01B |
$-0.01B |
-108.33% |
| 2023-05-31 |
$0.00B |
$-0.03B |
-3300.00% |
| 2023-02-28 |
$0.01B |
$-0.04B |
-300.00% |
| 2022-11-30 |
$0.01B |
$-0.04B |
-300.00% |
| 2022-08-31 |
$0.01B |
$-0.03B |
-283.33% |
| 2022-05-31 |
$0.02B |
$-0.01B |
-56.52% |
| 2022-02-28 |
$0.01B |
$-0.01B |
-81.82% |
| 2021-11-30 |
$0.01B |
$-0.01B |
-50.00% |
| 2021-08-31 |
$0.01B |
$-0.00B |
-44.44% |
| 2021-05-31 |
$0.01B |
$-0.01B |
-75.00% |
| 2021-02-28 |
$0.01B |
$-0.01B |
-85.71% |
| 2020-11-30 |
$0.01B |
$-0.01B |
-85.71% |
| 2020-08-31 |
$0.01B |
$-0.01B |
-62.50% |
| 2020-05-31 |
$0.01B |
$-0.00B |
-12.50% |
| 2020-02-29 |
$0.01B |
$-0.00B |
-11.11% |
| 2019-11-30 |
$0.01B |
0 |
0.00% |
| 2019-08-31 |
$0.01B |
0 |
0.00% |
| 2019-05-31 |
$0.01B |
0 |
0.00% |
| 2019-02-28 |
$0.01B |
0 |
0.00% |
| 2018-11-30 |
$0.01B |
$-0.00B |
-12.50% |
| 2018-08-31 |
$0.01B |
$-0.00B |
-12.50% |
| 2018-05-31 |
$0.01B |
$-0.00B |
-12.50% |
| 2018-02-28 |
$0.01B |
$-0.00B |
-12.50% |
| 2017-08-31 |
$0.01B |
0 |
0.00% |
| 2016-11-30 |
$0.00B |
0 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.011B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
